<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-2PH5KYAM</identifier><date>1998</date><creator>Jereb, Berta</creator><relation>documents/doc/2/URN_NBN_SI_doc-2PH5KYAM_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2PH5KYAM_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 61-67</format><identifier identifier_type="COBISSID_HOST">9648089</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2PH5KYAM</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Carcinoma, non-small-cell lung</subject><subject language_type_id="eng">Interferon-alpha</subject><subject language_type_id="eng">Lung neoplasms</subject><subject language_type_id="eng">Mortality</subject><subject language_type_id="eng">Pleural effusion, malignant</subject><subject language_type_id="eng">Therapy</subject><title>Zdravljenje bolnikov s plevralno karcinozo pri nemikrocelularnem (NMCCP) karcinomu s humanim interferonom alfa (INFA-alfa)</title></Record>